Search - tctmd.com

Displaying 1 - 20 of 131

Sort: Relevancy | Date

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

Presenter: Francesco Amata

October 29, 2024

Presentation TCT 2024

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

Presenter: Ryan Wallace

October 29, 2024

Presentation TCT 2024

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

Presenter: Stefano Galli

October 29, 2024

Presentation TCT 2024

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 29, 2024

Presentation TCT 2024

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

Presenter: Marta Mazur

October 29, 2024

Presentation TCT 2024

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

TCT 361: Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 27, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2024

TCT 360: Mechanisms of Lumen Reduction After Implantation of a Drug-Eluting Absorbable Metal Scaffold

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

Presentation TCT 2024

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

Presenter: Matthias Lutz

October 27, 2024

Presentation TCT 2023

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 25, 2023

Presentation TCT 2023

TCT 620: Positive Adaptive Remodeling Effect of the DynamX Bioadaptor in Bioadaptor RCT

Presenter: Mark Webster

October 25, 2023

Presentation TCT 2023

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 540: 12-Month Clinical Outcomes of Patients Treated with the novel DynamX Bioadaptor: DynamX Hong Kong Registry

Presenter: Wai Kin Chi

October 25, 2023

Presentation TCT 2023

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Presenter: SIMONE FEZZI

October 25, 2023

Presentation TCT 2023

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Presenter: Stefano Galli

October 25, 2023

Advertisement

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

TCT 361: Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

TCT 360: Mechanisms of Lumen Reduction After Implantation of a Drug-Eluting Absorbable Metal Scaffold

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

TCT 364: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions: 5 Clinical Year Outcomes

TCT 761: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 18 Month Outcomes – FANTOM STEMI Pilot Study

TCT 620: Positive Adaptive Remodeling Effect of the DynamX Bioadaptor in Bioadaptor RCT

TCT 575: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24 Month Clinical Outcomes in First 100 Patients

TCT 540: 12-Month Clinical Outcomes of Patients Treated with the novel DynamX Bioadaptor: DynamX Hong Kong Registry

TCT 497: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 4 Clinical Year Outcomes

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content